Headlines

Sypris Solutions Already 11% Down, Almost One Hour Before The NASDAQ Open

(VIANEWS) – The NASDAQ opens tomorrow, in less than one hours, and today’s Sypris Solutions (NASDAQ: SYPR)‘s post-market value is already 11.79% down. Sypris Solutions’s last close was $1.95, 15.22% below its 52-week high of $2.30. The last session, NASDAQ ended with Sypris Solutions (SYPR) rising 1.04% to $1.95. NASDAQ jumped 0.19% to $14,992.97, after…

Read More

TherapeuticsMD Already 4% Up, Almost Two Hours Before The Market Open

(VIANEWS) – The NASDAQ opens tomorrow, in less than two hours, and today’s TherapeuticsMD (NASDAQ: TXMD)‘s post-market value is already 4.76% up. TherapeuticsMD’s last close was $2.31, 64.41% below its 52-week high of $6.49. The last session, NASDAQ ended with TherapeuticsMD (TXMD) dropping 3.75% to $2.31. NASDAQ rose 0.19% to $14,992.97, after two successive sessions…

Read More

Quidel Already 5% Down, Almost Two Hours Before The NASDAQ Open

(VIANEWS) – The NASDAQ opens tomorrow, in less than two hours, and today’s Quidel (NASDAQ: QDEL)‘s post-market value is already 5.38% down. Quidel’s last close was $73.98, 25.02% below its 52-week high of $98.67. The last session, NASDAQ finished with Quidel (QDEL) rising 0.27% to $73.98. NASDAQ rose 0.19% to $14,992.97, after two successive sessions…

Read More

ZoomInfo Soars 31% In Just 21 Sessions: Is It Time To Buy?

(VIANEWS) – ZoomInfo (NASDAQ: ZI) shares have experienced an astounding 31.83% surge over 21 trading sessions since November 24th from EUR14.17 on November 24th to EUR18.68 as of 04:17 EST Tuesday afternoon, after witnessing a downward trend the previous session. As such, ZoomInfo’s stock currently sits 0.19% higher at EUR14,992.97 following two consecutive gains by…

Read More

Arcturus Therapeutics Stock Soars 32% In 21 Sessions: Why The Bullish Trend?

(VIANEWS) – Arcturus Therapeutics stock price increased 32.58% over 21 sessions, from EUR23.91 on November 24th to EUR31.70 as of 03:37 EST Tuesday afternoon after two consecutive days of gains. This surge was in line with overall performance on NASDAQ, which gained 0.19% to EUR14,992.97 despite Arcturus Therapeutics trading 16.03% below its 52-week high of…

Read More